James Yang Liu's Insider Trades & SAST Disclosures
James Yang Liu's most recent trade in Oncocyte Corporation was a trade of 10,000 Option to Purchase Common Stock done . Disclosure was reported to the exchange on May 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Yang Liu.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncocyte Corporation | James Yang Liu | Sr Dir., Cntlr, PAO, Int PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
| Oncocyte Corporation | James Yang Liu | Controller, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 57,065 | 57,065 | - | - | Option to Purchase Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges